500,000 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Acquired by Integral Health Asset Management LLC

Integral Health Asset Management LLC bought a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 500,000 shares of the pharmacy operator's stock, valued at approximately $4,665,000. Integral Health Asset Management LLC owned about 0.06% of Walgreens Boots Alliance as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in the business. Franklin Resources Inc. increased its stake in shares of Walgreens Boots Alliance by 54.4% in the third quarter. Franklin Resources Inc. now owns 321,425 shares of the pharmacy operator's stock worth $2,893,000 after buying an additional 113,242 shares during the period. Czech National Bank grew its holdings in Walgreens Boots Alliance by 6.6% in the 4th quarter. Czech National Bank now owns 155,625 shares of the pharmacy operator's stock worth $1,452,000 after acquiring an additional 9,663 shares during the last quarter. Moody National Bank Trust Division increased its position in shares of Walgreens Boots Alliance by 17.6% in the fourth quarter. Moody National Bank Trust Division now owns 32,026 shares of the pharmacy operator's stock valued at $299,000 after acquiring an additional 4,782 shares during the period. Elevated Capital Advisors LLC raised its stake in shares of Walgreens Boots Alliance by 8.9% during the fourth quarter. Elevated Capital Advisors LLC now owns 58,395 shares of the pharmacy operator's stock valued at $545,000 after acquiring an additional 4,790 shares during the last quarter. Finally, First Financial Corp IN boosted its holdings in shares of Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock worth $25,000 after purchasing an additional 885 shares during the period. Hedge funds and other institutional investors own 58.59% of the company's stock.

Insiders Place Their Bets

In related news, Chairman Stefano Pessina purchased 832,258 shares of the stock in a transaction dated Sunday, April 27th. The stock was purchased at an average price of $11.01 per share, with a total value of $9,163,160.58. Following the transaction, the chairman now directly owns 145,621,079 shares in the company, valued at $1,603,288,079.79. This trade represents a 0.57% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 17.50% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. StockNews.com began coverage on Walgreens Boots Alliance in a report on Tuesday. They set a "hold" rating on the stock. Truist Financial reduced their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research note on Friday, January 31st. Wolfe Research upgraded Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and cut their price target for the company from $11.00 to $9.00 in a report on Friday, February 28th. Finally, Royal Bank of Canada boosted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research report on Wednesday, January 15th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $10.59.

Walgreens Boots Alliance Stock Up 0.4%

Shares of NASDAQ WBA traded up $0.05 during mid-day trading on Thursday, hitting $11.18. 5,912,251 shares of the stock traded hands, compared to its average volume of 21,012,124. The company has a market cap of $9.67 billion, a price-to-earnings ratio of -1.09, a PEG ratio of 1.31 and a beta of 0.77. The stock has a fifty day moving average price of $11.02 and a 200-day moving average price of $10.32. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $18.53. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, beating analysts' consensus estimates of $0.53 by $0.10. The firm had revenue of $38.59 billion for the quarter, compared to analysts' expectations of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company's quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.20 EPS. Research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.